Citigroup Maintains Neutral on RXO, Lowers Price Target to $23

Benzinga Newsdesk www.benzinga.com Negative 77.6%

Neg 77.6% Neu 0% Pos 0%

Citigroup analyst Ariel Rosa maintains RXO (NYSE:RXO) with a Neutral and lowers the price target from $30 to $23.

Comments

No comments yet. Be the first!